Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.5.2.34SWon-SCTACATGCACCAGCAACTGT20502311423133F-10601.4South Korea
CJ.1.2SWon-SCTACATGCACCAGCAACTGT20502311423133F-10601.4South Korea
BQ.1.1.21SWon-SCTACATGCACCAGCAACTGT20502311423133F-10601.4South Korea
BQ.1.22SWon-SCTACATGCACCAGCAACTGT20502311423133F-10601.4South Korea
BF.7.19SWon-SCTACATGCACCAGCAACTGT20502311423133F-10601.4South Korea
FA.1SWon-SCTACATGCACCAGCAACTGT20502311423133F-10601.4South Korea
EE.4SWon-SCTACATGCACCAGCAACTGT20502311423133F-10601.4South Korea
BQ.1.1.72SWon-SCTACATGCACCAGCAACTGT20502311423133F-10601.4South Korea
B.1.232SWon-SCTACATGCACCAGCAACTGT20502311423133F-10601.4South Korea
BN.1.9SWon-SCTACATGCACCAGCAACTGT20502311423133F-10601.4South Korea
BQ.1.1.22SWon-SCTACATGCACCAGCAACTGT20502311423133F-10601.4South Korea
JC.1SWon-SCTACATGCACCAGCAACTGT20502311423133F-10601.4South Korea
BA.5.11SWon-SCTACATGCACCAGCAACTGT20502311423133F-10601.4South Korea
B.1.274SWon-SCTACATGCACCAGCAACTGT20502311423133F-10601.4South Korea
B.1.1.112SWon-SCTACATGCACCAGCAACTGT20502311423133F-10601.4South Korea
B.1.1.424SWon-SCTACATGCACCAGCAACTGT20502311423133F-10601.4South Korea
XBF.7.1SWon-SCTACATGCACCAGCAACTGT20502311423133F-10601.4South Korea
HC.1SWon-SCTACATGCACCAGCAACTGT20502311423133F-10601.4South Korea
XCJSWon-SCTACATGCACCAGCAACTGT20502311423133F-10601.4South Korea
FT.2SWon-SCTACATGCACCAGCAACTGT20502311423133F-10601.4South Korea
EP.1SWon-SCTACATGCACCAGCAACTGT20502311423133F-10601.4South Korea
FL.17.2SWon-SCTACATGCACCAGCAACTGT20502311423133F-10601.4South Korea
EG.12SWon-SCTACATGCACCAGCAACTGT20502311423133F-10601.4South Korea
BA.4.6.2SWon-SCTACATGCACCAGCAACTGT20502311423133F-10601.4South Korea
FP.1SWon-SCTACATGCACCAGCAACTGT20502311423133F-10601.4South Korea
XBF.2SWon-SCTACATGCACCAGCAACTGT20502311423133F-10601.4South Korea
B.1.177.52SWon-SCTACATGCACCAGCAACTGT20502311423133F-10601.4South Korea
B.50ORF1abNIID WH-1 F501R913TTCGGATGCTCGAACTGCACC2157.14484504F-10582.8Japan
BF.7.17NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-10472.1China
BA.2.86.6ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-10265.3Japan
B.1.137NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-10257.2Singapore
B.1.137ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-10157.8Germany
HK.34.1ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-10157.8Germany
XRORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-10157.8Germany
BA.5.2.38ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-10157.8Germany
BA.2.9.2ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-10157.8Germany
CP.1.3ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-10157.8Germany
FZ.1ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-10157.8Germany
BA.4.8ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-10157.8Germany
BN.4ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-10157.8Germany
LT.1ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-10157.8Germany
LV.2ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-10157.8Germany
BA.5.2.8ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-10157.8Germany
BF.11.2ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-10157.8Germany
AY.4.2.2 (Delta)ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-10157.8Germany
AY.34.1 (Delta)ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-10157.8Germany
CH.1.1.13ENiu-ECACGTTAACAATATTGCAGC20402639126372R-10155.5China
JN.3.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-10155.5China
CQ.2ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-10154.2South Korea
CK.1.1.2ORF1abChan-ORF1abGTGTGATGTTGAWATGACATGGTC2441.671635316330R-10094.6China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used